GlycanAge
London-headquartered GlycanAge, spun out of Croatian glycoscience research, markets a biological-age test based on immunoglobulin G (IgG) glycosylation rather than DNA methylation; a May 2026 study run jointly with Circulate Health analyzed roughly 20,000 individuals across 42 studies,…
- Country
- United Kingdom
glycan-clock
eu
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Epigenetic clocks & biological-age diagnostics | diagnostics-medtech | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.